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Abstract
Background: The IL-4, IL-4 receptor (IL4R), and IL-13 genes are crucial immune factors and may influence the course of
various diseases. In the present study, we investigated the association between the potential functional polymorphisms in
IL-4, IL-4R, and IL-13 and coal workers’ pneumoconiosis (CWP) risk in a Chinese population.
Methods: Six polymorphisms (C-590T in IL-4, Ile50Val, Ser478Pro, and Gln551Arg in IL-4R, C-1055T and Arg130Gln in IL-13)
were genotyped and analyzed in a case-control study of 556 CWP and 541 control subjects.
Results: Our results revealed that the IL-4 CT/CC genotypes were associated with a significantly decreased risk of CWP (odds
ratio (OR)=0.74, 95% confidence interval (CI)=0.58–0.95), compared with the TT genotype, particularly among subgroups
of age ,65 years (OR=0.68, 95%CI=0.46–0.99) and dust exposure years $26 years (OR=0.69, 95%CI=0.50–0.94).
Moreover, the polymorphism was significantly associated with risk of CWP patients with stage I. In addition, a combined
effect was observed in a dose-dependent manner with increasing numbers of risk variant alleles (Ptrend=0.023), and
individuals with 11–12 risk alleles had a 47% higher risk of CWP than those with 0–8 risk alleles (OR=1.47, 95% CI=1.05–
2.05).
Conclusions: Our results suggest that the IL-4 C-590T polymorphism is involved in the etiology of CWP and susceptibility to
this disease. Larger studies are warranted to validate our findings.
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Introduction
Coal workers’ pneumoconiosis (CWP) is a lung disease caused by
the inhalation and deposition of occupational coal mine dust in the
lungs. The incidence and rate of CWP progression is related to the
amount of respirable coal dust or silica to which coal miners were
exposed during their work [1]. In China, workers exposed to coal
dust or silica have increasing morbidity and mortality annually [2].
Although the exact mechanisms leading to CWP are yet to be
elucidated, current evidence suggests that CWP is characterized by
chronic pulmonary inflammation and fibrotic nodular lesions that
usually lead to progressive fibrosis [3]. CWP can be diagnosed
among workers who have worked in poor workplace environments
twoto threedecades agoeven though theirwork environmentshave
been improved [4]. Therefore, identification of new genetic factors
for CWP would improve diagnosis of patients at risk and help
determine effective prophylactic intervention.
The IL-4 and IL-13 cytokines share many structural and
functional similarities, as well as a common receptor component,
IL-4 receptor (IL4R), located on chromosome 16p11. IL-4 plays
important roles in the differentiation of T cells, eosinophilic
inflammation, and isotype switching in B cells from IgM to IgE
[5]. It reduces the production of proinflammatory cytokines and
destructive enzymes by monocytes [6]. IL-4 is also a key factor in
the polarization of T helper cells toward Th2 differentiation [7].
IL-13 is a central immune regulator of many allergic character-
istics, including IgE synthesis, mucus hypersecretion, airway
hyperreactivity, and fibrosis [8], which is found to be overex-
pressed in the lungs of patients and in murine models [9]. IL-13
shares overlapping biological functions with IL-4, and mediates its
effect through the IL-4R [10]. Therefore, polymorphisms in IL-4,
IL-4R, and IL-13 genes may constitute a common etiologic
pathway in CWP patients. To determine whether polymorphisms
in IL-4, IL-4R, and IL-13 genes contribute to the development of
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promoter region), IL-4R Ile50Val (rs1805010 in the IL-4R exon 5),
IL-4R Ser478Pro (rs1805015 in the IL-4R exon 12), IL-4R
Gln551Arg (rs1801275 in the IL-4R exon 12), IL-13 C-1055T
(rs1800925 in the IL-13 promoter region) and IL-13 Arg130Gln
(rs20541 in the IL-13 exon 4) polymorphisms and investigated the
association between these genetic variants and CWP risk in a
Chinese population.
Materials and Methods
Study subjects
The detailed methods of recruiting study subjects for this study
have been described previously [11]. Briefly, 556 CWP patients
and 541 controls were recruited in an ongoing study from five coal
mines of Xuzhou Mining Business Group Co. Ltd., China, starting
in January 2006. The high kilovolt chest X-ray and physical
examinations were performed for reconfirming the diagnoses
based on the China National Diagnostic Criteria for Pneumoco-
niosis (GBZ 70-2002), which is the same as the 1980 International
Labour Organization (ILO) Classification of Pneumoconiosis in
the judgment of opacity profusion. The pneumoconiosis patients
were classified into stage I, stage II and stage III according to the
size, profusion, and distribution range of opacities on chest X-ray.
The chest X-rays were assessed by two independent physicians (Z
Song and X Jia). The controls were selected from the same coal
mines, who were matched for age (within 5 years), dust exposure
period, and job type. Subjects were excluded if they had clinical
evidence of autoimmunity diseases; had immunosuppressive or
immunostimulatory therapy, or were subjected to radiotherapy.
The epidemiological survey was done by face-to-face interviewers
in order to obtain correct information including age, dust exposure
period, job types, smoking status and others. The questionnaire
was blinded regarding the case or control status of participants.
After the interview, a 5 mL venous blood sample was collected
from each subject. Informed consent was obtained from all
subjects and the authorization was given by the Institutional
Review Board of Nanjing Medical University.
Genotyping
Genomic DNA was isolated from peripheral blood lymphocytes
using the conventional phenol-chloroform method. Genotyping
was performed using the TaqMan method with ABI 7900HT Real
Time PCR system according to the manufacturer’s instructions
(Applied Biosystem, Foster city, CA). The sequences of primer and
probe for each SNP are available on request. A total of 10 negative
controls and 8 duplicates were included for each SNP as a quality
control measure. About 10% of the samples were randomly
selected for repeated genotyping for confirmation and the results
were 100% concordant. Genotyping was performed by two
persons independently in a blinded fashion.
Statistical analyses
Differences in the distributions of demographic characteristics,
selected variables, and frequencies of genotypes of IL-4, IL-4R,a n d
IL-13 polymorphisms between the CWP cases and controls were
evaluated by using the Student’s t-test (for continuous variables)or x
2-
test (for categorical variables). Hardy-Weinberg equilibrium (HWE)
was tested using a goodness-of-fit x
2-test. The associations between
genotypes and CWP were estimated by computing odds ratios (ORs)
and their 95% confidence intervals (CIs) from unconditional logistic
regression analysis with the adjustment for possible confounders. For
the stratified analysis, the age and dust-exposure cutoff used in this
study were according to the median of age and dust-exposure year of
the recruited patients and controls. The statistical power was
calculated by using the PS software (http://biostat.mc.vanderbilt.
edu/twiki/bin/view/Main/PowerSampleSize). EM algorithm in
SAS 9.1 PROC HAPLOTYPE was used to infer haplotype fre-
quencies based on observed genotypes. All tests were two-sided by
using the SAS software (version 9.1; SAS Institute, Inc., Cary, NC),
unless indicated otherwise.
Results
The distributions of selected characteristics between CWP
patients and control subjects are shown in Table 1. Briefly, there
was no significant difference in the distribution of age (P=0.304),
Table 1. Demographic and selected variables among the
CWP cases and control subjects.
Variables CWP (n=556)
Controls
(n=541) P
N% N %
Age, year (mean 6 SD) 65.3610.5 64.867.2 0.304
Exposure years (mean 6 SD) 26.569.1 26.968.0 0.452
Smoking status 0.002
Never 273 49.1 317 58.6
Ever 283 50.9 224 41.4
Former 121 21.8 25 4.6
Current 162 29.1 199 36.8
Pack-years smoked ,0.001
0 273 49.1 317 58.6
0–20 183 32.9 81 15.0
.20 100 18.0 143 26.4
Job type 0.106
Tunnel and coal mining 525 94.4 522 96.5
Transport 15 2.7 13 2.4
Others 16 2.9 6 1.1
Stage
I 315 56.7
II 190 34.2
III 51 9.1
doi:10.1371/journal.pone.0022624.t001
Table 2. Primary information of genotyped SNPs.
SNP rs no.
a Location Base MAF HWE
b
Case Control
IL4 C-590T rs2243250 Promoter T.C 0.186 0.223 0.340
IL4R Ile50Val rs1805010 Exon 5 C.T 0.482 0.500 0.636
IL4R Ser478Pro rs1805015 Exon 12 T.C 0.081 0.087 0.029
IL4R Gln551Arg rs1801275 Exon 12 A.G 0.156 0.167 0.716
IL13 C-1055T rs1800925 Promoter C.T 0.159 0.165 0.690
IL13 Arg130Gln rs20541 Exon 4 G.A 0.272 0.300 0.054
aSNP rs no. were taken from NCBI dbSNP (http://www.ncbi.nlm.nih.gov/SNP).
bHWE P value in the control group.
doi:10.1371/journal.pone.0022624.t002
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cases and controls. However, there were more ever smokers
(50.9%) among the cases than among the controls (41.4%)
(P=0.002). Specially, light smokers (#20 pack-years) had a 2.62-
fold (95% CI=1.93–3.57) increased risk. Furthermore, the stages
from I to III of the cases were 56.7%, 34.2%, and 9.1%,
respectively.
The primary information and allele frequencies observed are
listed in Table 2. All genotyped distributions of control subjects
were consistent with those expected from the Hardy-Weinberg
equilibrium except for Ser478Pro polymorphism in the IL-4R
exon 12 (P=0.029). The minor allele frequency (MAF) of all
the six polymorphisms was consistent with that reported in the
HapMap database. As shown in Table 3, only the genotype
frequencies of C-590T polymorphism in the IL-4 promoter
region were significantly different between the cases and
controls (P=0.049 and 0.034 for genotype and allele,
respectively). But this significance disappeared after the
Bonferroni correction. Logistic regression analysis revealed
that the IL-4 C-590T CT genotype, but not the CC genotype,
Table 3. Distributions of genotypes of IL-4, IL-4R and IL-13 their associations with risk of CWP.
Variables CWP cases Controls P
a OR (95% CI) OR (95% CI)
b
N% N %
IL4 C-590T n=553 n=541
TT 369 66.7 323 59.7 0.049 1.00 1.00
CT 162 29.3 195 36.0 0.72 (0.56–0.93) 0.71 (0.55–0.92)
CC 22 4.0 23 4.3 0.83 (0.45–1.52) 0.85 (0.46–1.53)
CT/CC 184 33.3 218 40.3 0.016 0.74 (0.58–0.95) 0.73 (0.57–0.94)
T allele 900 81.4 841 77.7 0.034 1.00
C allele 206 18.6 241 22.3 0.80 (0.65–0.98)
IL4R Ile50Val n=556 n=539
CC 145 26.1 138 25.6 0.512 1.00 1.00
CT 286 51.4 264 49.0 1.05 (0.79–1.39) 1.06 (0.80–1.42)
TT 125 22.5 137 25.4 0.88 (0.63–1.23) 0.89 (0.64–1.25)
C allele 576 51.8 540 50.0 0.425 1.00
T allele 536 48.2 538 50.0 0.93 (0.79–1.10)
IL4R Ser478Pro n=554 n=538
TT 468 84.5 445 82.7 0.141 1.00 1.00
CT 83 15.0 93 17.3 0.85 (0.62–1.18) 0.83 (0.60–1.15)
CC 3 0.5 0 0.0 - -
T allele 1019 92.0 983 91.4 0.606 1.00
C allele 89 8.0 93 8.6 0.92 (0.68–1.25)
IL4R Gln551Arg n=553 n=534
AA 393 71.1 372 69.7 0.756 1.00 1.00
AG 147 26.6 146 27.3 0.96 (0.74–1.26) 0.96 (0.73–1.25)
GG 13 2.3 16 3.0 0.78 (0.37–1.64) 0.78 (0.37–1.66)
A allele 933 84.4 890 83.3 0.516 1.00
G allele 173 15.6 178 16.7 0.93 (0.74–1.17)
IL13 C-1055T n=552 n=538
CC 396 71.7 376 69.9 0.643 1.00 1.00
CT 137 24.8 146 27.1 0.89 (0.68–1.17) 0.90 (0.68–1.18)
TT 19 3.4 16 3.0 1.13 (0.57–2.22) 1.12 (0.57–2.22)
C allele 929 84.1 898 83.5 0.661 1.00
T allele 175 15.9 178 16.5 0.95 (0.76–1.19)
IL13 Arg130Gln n=554 n=539
GG 294 53.1 255 47.3 0.131 1.00 1.00
AG 219 39.5 245 45.5 0.78 (0.61–0.99) 0.80 (0.62–1.02)
AA 41 7.4 39 7.2 0.91 (0.57–1.46) 0.94 (0.58–1.50)
G allele 807 72.8 755 70.0 0.148 1.00
A allele 301 27.2 323 30.0 0.87 (0.72–1.05)
aTwo-sided x
2 test.
bAdjusted for age, exposure years, pack-years of smoking, and job type.
doi:10.1371/journal.pone.0022624.t003
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compared with the TT genotype (OR=0.71, 95%CI=0.55–
0.92 for CT versus TT; and OR=0.85, 95%CI=0.46–1.53 for
CC versus TT). Individuals with the C allele had a decreased
risk of CWP, compared with those carrying the T allele
(OR=0.80, 95%CI=0.65–0.98). Furthermore, a significant
protective effect of CWP was found in the combined genotypes
CT/CC, compared with the TT genotype (OR=0.73,
95%CI=0.57–0.94). However, no significant association with
CWP was identified for the other polymorphisms examined in
this study.
In the stratification analyses, we found that individuals with the
IL-4 CT/CC genotypes had a significant decreased risk of CWP
than those with the TT genotype, and this decreased risk was
more evident among subgroups of age ,65 years (OR=0.68,
95%CI=0.46–0.99) and dust exposure years $26 years (OR=
0.69, 95%CI=0.50–0.94) (Table 4). In addition, significant
associations were observed between the genotypes and patients
with stage I (OR=0.70, 95%CI=0.52–0.95). However, no
statistical evidence was found for the gene-environment interaction
(data not shown).
Considering potential interactions of these cytokine gene
polymorphisms on risk CWP, we combined these six polymor-
phisms based on the numbers of variant (risk) alleles (i.e., IL-4
rs2243250 T, IL-4R rs1805010 C, IL-4R rs1805015 T, IL-4R
rs1801275 A, IL-13 rs1800925 C, and IL-13 rs20541 G alleles). As
shown in Table 5, individuals with multiple risk alleles had a
higher risk of CWP, compared with those with 0–8 risk alleles,
with a dose-dependent manner with increasing numbers of risk
variant alleles conferring increasing risk (Ptrend=0.023). Specifi-
cally, individuals carrying 11–12 risk alleles had a significantly
higher risk of CWP than those with 0–8 risk alleles (OR=1.47,
95% CI=1.05–2.05).
Haplotypes analysis of IL-4R and IL-13 polymorphisms was
performed. However, the distributions of the haplotypes of IL-4R
and IL-13 between the CWP cases and controls were not
significantly different, and the haplotypes had no apparent
relationship with risk of CWP (data not shown).
Discussion
In this case-control study, six functional polymorphisms in the
IL-4, IL-4R, and IL-13 genes were investigated with respect to an
association with risk of CWP in a Chinese population. We found
that the IL-4 C-590T polymorphism in the promoter region was
significantly associated with CWP, and the association was more
evident in younger workers with a long exposure history.
CWP is a chronic inflammatory lung disease where various
environmental and genetic factors can influence its phenotype.
Genetic factors such as polymorphisms can contribute to the
extent or severity of CWP. Many genetic studies in CWP patients
have involved genes encoding for cytokines and their receptors
[12,13,14]. Cytokines play a crucial role in the widely used
immunological model that explain the increasing prevalence of
Table 4. Stratification analyses between the genotypes of IL-4 C-590T polymorphism and CWP risk.
Variables Cases/controls Genotypes (cases/controls) P OR (95% CI)
a
TT CT/CC
n % n %
Total 553/541 369/323 66.7/59.7 184/218 33.3/40.3 0.016 0.73 (0.57–0.94)
Age
,65 214/257 147/155 68.7/60.3 67/102 31.3/39.7 0.049 0.68 (0.46–0.99)
$65 339/284 222/168 65.5/59.2 117/116 34.5/40.8 0.130 0.78 (0.56–1.08)
Exposure years
,26 192/182 122/107 63.5/58.5 70/75 36.5/41.2 0.397 0.83 (0.55–1.27)
$26 361/359 247/216 68.4/60.2 114/143 31.6/39.8 0.018 0.69 (0.50–0.94)
Smoking status
Never 272/317 180/187 66.2/59.0 187/130 33.8/41.0 0.064 0.73 (0.52–1.02)
Ever 281/224 189/136 67.3/60.7 92/88 32.7/39.3 0.116 0.74 (0.51–1.08)
Stage
I 314/541 213/323 67.8/59.7 101/218 32.2/40.3 0.020 0.70 (0.52–0.95)
II 188/541 124/323 66.0/59.7 64/218 34.0/40.3 0.177 0.78 (0.54–1.12)
III 51/541 32/323 62.8/59.7 19/218 37.2/40.3 0.852 0.94 (0.50–1.78)
aAdjusted for age, exposure years, pack-years of smoking, and job type.
doi:10.1371/journal.pone.0022624.t004
Table 5. Frequency distributions of the combined genotypes
of IL-4, IL-4R and IL-13 between CWP cases and controls.
No. of risk alleles
a Cases Controls OR (95%CI)
b P
No. % No. %
0–8 151 27.8 178 33.7 1.00
9 117 21.5 112 21.2 1.25 (0.89–1.74) 0.196
10 147 27.0 136 25.8 1.28 (0.93–1.76) 0.125
11–12 129 23.7 102 19.3 1.47 (1.05–2.05) 0.025
Ptrend 0.023
aRisk alleles included IL-4 rs2243250 T, IL-4R rs1805010 C, IL-4R rs1805015 T, IL-
4R rs1801275 A, IL-13 rs1800925 C, and IL-13 rs20541 G alleles.
bAdjusted for age, exposure years, pack-years of smoking, and job type.
doi:10.1371/journal.pone.0022624.t005
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Th2 immune response [15]. IL-4 is a typical Th2 cytokine of
decisive significance in regulating Th1/Th2 cytokine balance [16].
It plays an important role through the IL-4R [17]. IL-4R binds not
only IL-4, but also IL-13. IL-4 is dominant mediator of Th2 cell
differentiation, proliferation, and activity, whereas IL-13 has
minimal effects on T cell function [18]. A recent study reported
that a promoter polymorphism C-590T of IL-4 was associated
with an increased gene expression with T allele [19]. The -590T
promoter sequence showed greater binding to nuclear transcrip-
tion factors from allergen stimulated Jurkat human T cells than
that of -590C sequence, and alteration in electrophoretic mobility
shift assay was observed [20,21]. Several association studies have
demonstrated that the T allele was correlated to inflammatory
disease, such as asthma [22,23]. In the present study, carriers of
the TT genotype had an increased risk of CWP compared with the
CT/CC genotypes. One possible explanation is that the T allele
may result in increased anti-inflammatory cytokine production or
as a pro-fibrogenic factor favoring the fibrotic nodular lesions of
lung.
Polymorphisms leading to amino acid changes have been
described for mouse and human IL-4R [24]. Three functional
polymorphisms Ile50Val, Ser478Pro, and Gln551Arg in the exons
of IL-4R are frequently linked, which were associated with low
total IgE concentrations, and an increase in the phosphorylation of
insulin receptor substrate molecules [25]. However, the effects of
these polymorphisms on receptor signaling have been contradic-
tory [26,27,28]. IL-13 binds with high affinity to IL-13 receptor a-
1, which induces heterodimerization with IL-4R to form a complex
identical to the type II receptor [29]. Functional characterization
of IL-13 C-1055T polymorphism showed that T allele had
opposite transcriptional effects, paralleled by distinct patterns of
DNA-protein interactions at the IL-13 promoter [30], which has
been shown to be associated with allergic asthma and abnormal
IL-13 production [31]. Another IL-13 Arg130Gln polymorphism
in exon 4 has been shown to be associated with high total serum
IgE level [32]. However, our study found that individuals with IL-
4R and IL-13 polymorphisms did not have an increased risk of
developing CWP. The mechanism of inconsistent results is still
unknown, which needs to be validated by other studies with
different ethnic populations.
Interestingly, we found that the protective effects of IL-4 variant
genotype were evident in younger workers with long exposure
history. Although the exact molecular mechanisms underlying are
unknown, it is possible that individuals in those subgroups more
likely were less exposed to some risk factors involved in the etiology
of CWP risk [33]. Hessel et al. performed a meta-analysis and
showed that smoking was significantly associated with silicosis
[34]. Animal studies also revealed that smoking could induce lung
fibrosis [35]. In the present study, we also found a significant
difference between smokers and non-smokers related to CWP risk
(P=0.002), but there was no difference between the smoking status
and CWP patients with different IL-4 C-590T genotypes. This
negative result in our study could be due to insufficient sample
size. Interestingly, we found that the IL-4 polymorphism carriers
had a significantly decreased risk of developing stage I CWP.
These findings suggested that there might be different mechanisms
underlying the early development of CWP and the subsequent
progression of CWP [36], and the IL-4 polymorphism might affect
these two mechanisms differently.
Several limitations of this study should be addressed. First, our
study was hospital-base study design, we could not rule the possible
of selection bias of subjects that may have been associated with a
particular genotype. Second, our sample size is moderate, and the
statistical power of the study is limited, especially for subgroup and
interaction analyses. However, we have 80% power at 0.05
significance level to detect an OR of 1.50 or higher and 0.63 or
lower with an exposure frequency of 20% under the current
sample size Third, because our results were based on the statistical
significance and the ORs were very weak, the significant
association between the IL-4 C-590T polymorphism and CWP
risk should be interpreted with caution. Further functional study is
needed to validate our findings.
In conclusion, our present study indicated that the functional
IL4 C-590 T polymorphism is associated with decreased risk of
CWP in a Chinese population. Further validation studies with
diverse populations are warranted to confirm our findings.
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